|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 Massachusetts Avenue, NW |
Address2 | Suite 610 |
City | Washingon |
State | DC |
Zip Code | 20001-1430 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Schaumburg |
State | IL |
Zip Code | 60173 |
Country | USA |
|
5. Senate ID# 10445-12
|
||||||||
|
6. House ID# 338760000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: MS. KATHERINE O. ORRICO |
Date | 7/19/2018 1:16:02 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S.794, Local Coverage Determination Clarification Act: Medicare coverage policy process
S.1301, Resident Physician Shortage Reduction Act: Graduate Medicare Education residency training support
S.2575, Audiology Patient Choice Act: direct access to audiology services in Medicare
H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act: Medicare coverage for non-opioid treatments for pain
H.R.2267, Resident Physician Shortage Reduction Act: Graduate Medicare Education residency training support
H.R. 2373, accreditation of osteopathic and medical residency training programs
H.R.3635, Local Coverage Determination Clarification Act of 2017: Medicare coverage policy process
No Bill: Medicare regulatory relief, including delay of global surgery data collection and repeal/delay of appropriate use criteria for advanced diagnostic imaging
No Bill: Prior authorization in Medicare Advantage
No bill: Expanding use of clincal data registries in Medicare
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 527, the Health Care Safety Net Enhancement Act of 2017: Medical liability protections for physicians providing EMTALA mandated care
S. 781, the Good Samaritan Health Professionals Act: Medical liability protections for physicians volunteering during a national disaster
S.1022, MISSION ZERO Act: Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act: To facilitate assignment of military trauma care providers to civilian trauma centers in order to maintain military trauma readiness and to support such centers
S. 2456, CARA 2.0 Act of 2018: Opioid prescription limits and reporting requirements
S. 2680, The Opioid Crisis Response Act of 2018: Opioid prescription limits and reporting requirements
S.2852 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act: Including Good Samaritan liability protections
H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act: Opioid prescription limits and reporting requirements
H.R. 548, the Health Care Safety Net Enhancement Act of 2017: Medical liability protections for physicians providing EMTALA mandated care
H.R. 880, Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act: To facilitate assignment of military trauma care providers to civilian trauma centers in order to maintain military trauma readiness and to support such centers
H.R. 1876, the Good Samaritan Health Professionals Act: Medical liability protections for physicians volunteering during a national disaster
H.R. 4482, the Opioid Abuse Deterrence, Research, and Recovery Act: Opioid prescription limits and reporting requirements
H.R.5311, the CARA 2.0 Act of 2018: Opioid prescription limits and reporting requirements
No House Bill Number: Pandemic and All-Hazards Preparedness Reauthorization Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act: NIH funding, trauma/emergency care programs at CDC
No House Bill Number, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act: NIH funding, trauma/emergency care programs at CDC
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R.184, Protect Medical Innovation Act: Repeal of the medical device excise tax
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |